CYP20A1


CYP20A1: The Enzyme that Regulates Vitamin D Production

Description

Cytochrome P450 family 20 subfamily A member 1 (CYP20A1) is an enzyme responsible for catalyzing the hydroxylation of 25-hydroxyvitamin D3 (25(OH)D3) to 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3), the active form of vitamin D. CYP20A1 is primarily expressed in the proximal convoluted tubule cells of the kidney and plays a crucial role in maintaining calcium and phosphate homeostasis, bone mineralization, and immune function.

Associated Diseases

Mutations or deficiencies in CYP20A1 can lead to several health conditions:

  • Vitamin D-Dependent Rickets Type 1: An inherited disorder caused by mutations in CYP20A1 that results in impaired conversion of 25(OH)D3 to 1,25(OH)2D3. This leads to severe bone deformities and growth retardation.
  • Pseudo-Vitamin D Deficiency Rickets: A rare condition characterized by normal levels of 25(OH)D3 but low levels of 1,25(OH)2D3 due to impaired CYP20A1 function. This results in similar symptoms as vitamin D-dependent rickets type 1.
  • Hypocalcemia and Hyperparathyroidism: Deficiencies in CYP20A1 can reduce 1,25(OH)2D3 levels, leading to impaired calcium absorption and subsequent hypocalcemia and hyperparathyroidism.

Did you Know ?

In the United States, the prevalence of vitamin D deficiency is estimated to be around 40%. Vitamin D deficiency can result from inadequate sunlight exposure, dietary deficiencies, or genetic variations that affect CYP20A1 function.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.